Inventor · disambiguated record
Michael J. Cope
Also filed as: COPE MICHAEL · COPE MICHAEL J · COPE MICHAEL JAMES
27 granted patents·17 pending applications·261 citations·filing 1980–2023
96Inventor score
Top patents by PatentIndex Score
44 records- 0198US9993500B2Proton-binding polymers for oral administrationTRICIDA INC·Filed 2017·Granted Jun 12, 2018·15 cites·32 claims
- 0297US9925214B2Proton-binding polymers for oral administrationTRICIDA INC·Filed 2015·Granted Mar 27, 2018·13 cites·53 claims
- 0396US10369169B1Proton-binding polymers for oral administrationTRICIDA INC·Filed 2019·Granted Aug 6, 2019·8 cites·21 claims
- 0496US9205107B2Proton-binding polymers for oral administrationTRICIDA INC·Filed 2014·Granted Dec 8, 2015·22 cites·30 claims
- 0594US11406661B2HCl-binding compositions for and methods of treating acid-base disordersTRICIDA INC·Filed 2017·Granted Aug 9, 2022·4 cites·15 claims
- 0694US11197887B2Proton-binding polymers for oral administrationTRICIDA INC·Filed 2019·Granted Dec 14, 2021·4 cites·11 claims
- 0794US10363268B2Proton-binding polymers for oral administrationTRICIDA INC·Filed 2018·Granted Jul 30, 2019·8 cites·5 claims
- 0893US7556799B2Ion binding polymers and uses thereofRELYPSA INC·Filed 2005·Granted Jul 7, 2009·13 cites·19 claims
- 0992US10391118B2Proton-binding polymers for oral administrationTRICIDA INC·Filed 2018·Granted Aug 27, 2019·8 cites·46 claims
- 1091US11311571B2Proton-binding polymers for oral administrationTRICIDA INC·Filed 2015·Granted Apr 26, 2022·3 cites·11 claims
- 1191US7666898B2Multivalent indole compounds and use thereof as phospholipase-A2 inhibitorsILYPSA INC·Filed 2006·Granted Feb 23, 2010·34 cites·15 claims
- 1291US7488495B2Ion binding polymers and uses thereofRELYPSA INC·Filed 2004·Granted Feb 10, 2009·31 cites·20 claims
- 1391USD266040SSuspended chairCOPE MICHAEL J·Filed 1980·Granted Sep 7, 1982·34 cites·1 claims
- 1490US7589238B2Treatment of hyperphosphatemia using crosslinked small molecule amine polymersILYPSA INC·Filed 2006·Granted Sep 15, 2009·14 cites·66 claims
- 1589US7776319B2Methods and compositions for treatment of ion imbalancesRELYPSA INC·Filed 2005·Granted Aug 17, 2010·8 cites·15 claims
- 1688US11992501B2Compositions for and methods of treating acid-base disordersRENOSIS INC·Filed 2021·Granted May 28, 2024·1 cites·53 claims
- 1787US7854924B2Methods and compositions for treatment of ion imbalancesRELYPSA INC·Filed 2004·Granted Dec 21, 2010·18 cites·39 claims
- 1884US2023405043A1Proton-binding polymers for oral administrationRENOSIS INC·Filed 2023·Application pending·0 cites
- 1983US7608674B2Pharmaceutical compositions comprising cross-linked small molecule amine polymersILYPSA INC·Filed 2004·Granted Oct 27, 2009·16 cites·49 claims
- 2083US2022096534A1Proton-binding polymers for oral administrationTRICIDA INC·Filed 2021·Application pending·0 cites
- 2181US11738041B2Proton-binding polymers for oral administrationRENOSIS INC·Filed 2022·Granted Aug 29, 2023·0 cites·10 claims
- 2278US9301974B2Methods and compositions for selectively removing potassium ion from the gastrointestinal tract of a mammalRELYPSA INC·Filed 2013·Granted Apr 5, 2016·2 cites·26 claims
- 2375US2025009785A1Hcl-binding compositions for and methods of treating acid-base disordersRENOSIS INC·Filed 2022·Application pending·0 cites
- 2474US10272103B2Crosslinked polyvinylamine, polyallylamine, and polyethyleneimine for use as bile acid sequestrantsRELYPSA INC·Filed 2015·Granted Apr 30, 2019·2 cites·16 claims
- 2571US2021205351A1Compositions for treating acid-base disordersTRICIDA INC·Filed 2021·Application pending·0 cites
- 2670US10905711B2Methods and compositions for selectively removing potassium ion from the gastrointestinal tract of a mammalVIFOR INT LTD·Filed 2018·Granted Feb 2, 2021·0 cites·22 claims
- 2767US9181364B2Crosslinked polyvinylamine, polyallylamine, and polyethyleneimine for use as bile acid sequestrantsKOPPING JORDAN·Filed 2011·Granted Nov 10, 2015·2 cites·19 claims
- 2866US7718746B2Anion-binding polymers and uses thereofILYPSA INC·Filed 2009·Granted May 18, 2010·0 cites·20 claims
- 2965US9655920B2Amine polymers for use as bile acid sequestrantsCONNOR ERIC·Filed 2011·Granted May 23, 2017·1 cites·17 claims
- 3060US10058567B2Methods and compositions for selectively removing potassium ion from the gastrointestinal tract of a mammalRELYPSA INC·Filed 2016·Granted Aug 28, 2018·0 cites·14 claims
- 3160US2013259949A1Methods and compositions for selectively removing potassium ion from the gastrointestinal tract of a mammalRELYPSA INC·Filed 2013·Application pending·0 cites
- 3259US8617609B2Methods and compositions for selectively removing potassium ion from the gastrointestinal tract of a mammalCOPE MICHAEL J·Filed 2006·Granted Dec 31, 2013·0 cites·20 claims
- 3355US2006078534A1Toxin binding compositionsCHARMOT DOMINIQUE·Filed 2004·Application pending·0 cites
- 3454US2008021049A1Treatment Of Diet-Related Conditions Using Phospholipase-A2 Inhibitors Comprising Indoles And Related CompoundsBUYSSE JERRY M·Filed 2005·Application pending·0 cites
- 3554US2007292385A1Phospholipase Inhibitors Localized in the Gastrointestinal LumenCHARMOT DOMINIQUE·Filed 2005·Application pending·0 cites
- 3649US2019169342A1Polyimidazoles for use as bile acid sequestrantsRELYPSA INC·Filed 2019·Application pending·0 cites
- 3745US2017258825A1Amine polymers for use as bile acid sequestrantsRELYPSA INC·Filed 2017·Application pending·0 cites
- 3842US2006099169A1Toxin binding compositionsILYPSA INC·Filed 2005·Application pending·0 cites
- 3941US2013189215A1Polyimidazoles for use as bile acid sequestrantsLEES INEZ·Filed 2011·Application pending·0 cites
- 4037US2009318492A1Indole compounds having c4-acidic substituents and use thereof as phospholipase-a2 inhibitorsCHANG HAN-TING·Filed 2006·Application pending·0 cites
- 4137US2009306171A1Indole compounds having c4-amide substituents and use thereof as phospholipase-a2 inhibitorsCHANG HAN-TING·Filed 2006·Application pending·0 cites
- 4237US2009239896A1Azaindole compounds and use thereof as phospholipase-a2 inhibitorsCHANG HAN-TING·Filed 2006·Application pending·0 cites
- 4336US2007135383A1Phospholipase inhibitors, including multi-valent phospholipase inhibitors, and use thereof, including as lumen-localized phospholipase inhibitorsCHANG HAN-TING·Filed 2006·Application pending·0 cites
- 4435US2007041911A1Hfc solution formulations containing salbutamol hydrochloride or salbutamol citrateSCHMIDT FRIEDRICH·Filed 2006·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →